Search results
Results from the WOW.Com Content Network
Obstructive shock may be due to cardiac tamponade or a tension pneumothorax. [1] Distributive shock may be due to sepsis, anaphylaxis, injury to the upper spinal cord, or certain overdoses. [1] [4] The diagnosis is generally based on a combination of symptoms, physical examination, and laboratory tests. [2] A decreased pulse pressure (systolic ...
Hypovolemic shock is a form of shock caused by severe hypovolemia (insufficient blood volume or extracellular fluid in the body). [1] [2] It can be caused by severe dehydration or blood loss. [3] [2] Hypovolemic shock is a medical emergency; if left untreated, the insufficient blood flow can cause damage to organs, leading to multiple organ ...
Dosage typically includes information on the number of doses, intervals between administrations, and the overall treatment period. [3] For example, a dosage might be described as "200 mg twice daily for two weeks," where 200 mg represents the individual dose, twice daily indicates the frequency, and two weeks specifies the duration of treatment.
Spring-Loaded: the Bone Injection Gun (BIG) and the Pyng Medical Corporation FAST 1 The First Access for Shock and Trauma (FAST 1) spring-loaded device is designed for use in the sternum of an adult. The FAST 1 device consists of multiple needles in a probe that penetrates the manubrium once manual pressure is applied. [16]
For example, a person weighing 75 kg with burns to 20% of his or her body surface area would require 4 x 75 x 20 = 6,000 mL of fluid replacement within 24 hours. The first half of this amount is delivered within eight hours from the burn incident, and the remaining fluid is delivered in the next 16 hours.
Hypovolemia, also known as volume depletion or volume contraction, is a state of abnormally low extracellular fluid in the body. [1] This may be due to either a loss of both salt and water or a decrease in blood volume.
Dobutamine is administered as a racemic mixture consisting of both (+) and (−) isomers; the (+) isomer is a potent β 1 agonist and α 1 antagonist, while the (−) isomer is an α 1 agonist. [9] The administration of the racemate results in the overall β 1 agonism responsible for its activity.
Dextropropoxyphene [5] is an analgesic in the opioid category, patented in 1955 [6] and manufactured by Eli Lilly and Company.It is an optical isomer of levopropoxyphene.It is intended to treat mild pain and also has antitussive (cough suppressant) and local anaesthetic effects.